Mefloquine leads to higher AEs: vomiting compared with sulfadoxine‐pyrimethamine (high certainty).
Mefloquine probably leads to higher AEs: dizziness compared with sulfadoxine‐pyrimethamine (moderate certainty).
It is very uncertain whether topical repellents changes clinical malaria: P. falciparum compared with placebo or no treatment (very low certainty).
Topical repellents showed no clear difference in parasitaemia: P. falciparum compared with placebo or no treatment (low certainty).
Topical repellents showed no clear difference in clinical malaria: P. vivax compared with placebo or no treatment (low certainty).
Topical repellents showed no clear difference in parasitaemia: P. vivax compared with placebo or no treatment (low certainty).
ITC may leads to lower clinical malaria: P. falciparum compared with placebo or no treatment (low certainty).
ITC showed no clear difference in clinical malaria: P. vivax compared with placebo or no treatment (low certainty).
It is very uncertain whether spatial repellents changes parasitaemia Plasmodium spp. compared with placebo or no treatment (very low certainty).
It is very uncertain whether the intervention changes mortality All‐cause death (very low certainty).
The intervention showed no clear difference in neonatal mortality (low certainty).
The intervention probably leads to lower low birthweight (moderate certainty).
The intervention leads to lower placental parasitaemia (high certainty).
It is very uncertain whether the intervention changes mortality All‐cause death (very low certainty).
The intervention showed no clear difference in severe anaemia During the third trimester (low certainty).
The intervention leads to lower severe anaemia During the third trimester (high certainty).